In January 2016, letters were sent to healthcare professionals regarding fingolimod (Gilenya▼) and erlotinib (Tarceva)
In January 2016, letters were sent to healthcare professionals to notify about safety information for:
Article citation: Drug Safety Update volume 9 issue 6 February 2016: 3.
17 February 2016
Medicines and Healthcare products Regulatory Agency
Don’t include personal or financial information like your National Insurance number or credit card details.